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Aims: The establishment of a genetic knockoutmurinemodel of glutaric acidemia type I (GAI)with complete loss
of glutaryl-CoA dehydrogenase (GCDH) activity has been used to investigate the pathological mechanisms un-
derlying neurological symptoms in this disorder. However, very little has been reported on the neurobehavior
of GCDH deﬁcient mice (Gcdh−/−).
Mainmethods: In the present studywe evaluated physical (body andweight gain) and neuromotor development
(appearance of coat, upper incisor eruption, eye-opening day, motor coordination, muscular strength and
climbing), aswell as cognitive behavior (inhibitory avoidance) inGcdh−/−, as compared towild type (WT)mice.
Key ﬁndings:We found that Gcdh−/−mice did not differ in body and weight gain, appearance of coat, upper in-
cisor eruption, motor coordination andmuscular strength, but had a signiﬁcant delayed eye opening, implying a
mild impairment of neurodevelopment in these animals. Furthermore, the climbing behavior was signiﬁcantly
higher in Gcdh−/− as compared toWTmice, suggesting an altered dopaminergic function. Finally,Gcdh−/−mice
presented a deﬁcit of short- and long-term memories in the inhibitory avoidance task.
Signiﬁcance: Although it is difﬁcult to extrapolate the present ﬁndings to the human condition, our present data are
particularly interesting in view of the psychomotor/mental delay that occurs in a signiﬁcant number of GAI patients
with no previous history of acute encephalopathy with striatum destruction. Strict and early treatment possibly as-
sociated with novel therapies seems therefore important to prevent learning/memory disabilities in GAI patients.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Glutaric aciduria type I (GAI, MIM 231670) is an autosomal reces-
sive neurometabolic disorder caused by defects of the mitochondrial
matrix protein glutaryl-CoA dehydrogenase (GCDH, EC 1.3.99.7), an
enzyme involved in the degradation of the amino acids lysine,
hydroxylysine and tryptophan (Lamp et al., 2011). GCDH deﬁciency
leads to the accumulation of glutaric acid (GA) and to a lesser extent
of 3-hydroxyglutaric acid (3-HGA) and glutaconic acid in tissues and
body ﬂuids (Funk et al., 2005; Goodman et al., 1977).
Patients usually present macrocephaly with frontotemporal
atrophy at birth and marked dystonia and dyskinesia, followingca, Universidade Federal do Rio
35-003, Porto Alegre, RS, Brazil.
ier OA license.encephalopathic episodes accompanied by destruction of striatal neu-
rons with a subsequent irreversible disabling movement disorder
(Hauss-Wegrzyniak et al., 1998; Hoffmann and Zschocke, 1999;
Kölker et al., 2006). The progression of neurological symptoms with
mental developmental delay and hypotonia without acute episodes of
encephalopathy also occurs in a considerable number of patients
(Blass, 2001; Brennan et al., 1985; Hagberg and Mallard, 2005; Heales
et al., 1999; Kölker et al., 2011; Tanaka et al., 2006).
Neuroradiological imaging shows, besides striatal abnormalities oc-
curring during encephalopathic crises, chronic progressive changes in-
cluding widened Sylvian ﬁssures, cortical atrophy with frontotemporal
volume loss, delayed myelination, enlargement of the lateral ventricles
and subdural hemorrhages (Brennan et al., 1985; Brismar and Ozand,
1995; Hauss-Wegrzyniak et al., 1998; Heales et al., 1999; Schurr, 2002;
Tanaka et al., 2006). However, some of these neuropathological changes
may represent a maturation delay and may resolve in time (Brennan et
al., 1985).
138 E.N.B. Busanello et al. / Life Sciences 92 (2013) 137–142A knockout (KO) mice model of GAI with complete loss of GCDH
activity was established and proposed as a good model to investigate
the pathological mechanisms underlying brain damage in this disor-
der (Tretter and Adam-Vizi, 2000). GCDH deﬁcient (Gcdh−/−) mice
displayed diffuse spongiform myelinopathy similar to that observed
in human GAI in the frontal cortex, but did not develop striatal dam-
age with neuron loss or astrogliosis typical of the human disease even
when submitted to metabolic or infectious stress (Tretter and Adam-
Vizi, 2000). It was subsequently found that exposition of these ani-
mals to high protein or lysine intake resulted in striatal damage, be-
sides neuronal loss, myelin disruption and gliosis mostly in the
striatum and deep cortex, therefore better mimicking the human
pathological condition.
To the best of our knowledge there is only one report dealing with
neuropsychomotor development in Gcdh−/− mice (Tretter and Adam-
Vizi, 2000). It was observed minor behavioral alterations in these ani-
mals, including mild motor deﬁcit, detected by difﬁculty in righting
themselves when placed on their backs and impairment on the
rota-rod task with less time spent on the rod at asymptote. Gcdh−/−
mice also presented a failure to habituate in the repeated startle stimuli,
suggesting a defect in the elementary form of learning.
Therefore the present study aimed to evaluate comprehensively
physical (body and weight gain) and neuromotor development (ap-
pearance of coat, upper incisor eruption, eye-opening day, motor coor-
dination,muscular strength and climbing), aswell as cognitive behavior
(inhibitory avoidance) inGcdh−/− as compared towild type (WT)mice.
Experimental procedures
Animals
A total of twenty Gcdh−/− and the same number of wild type
(WT) mice, both male of 129SvEv background, were used in this
study. The Gcdh−/− mice were generated from heterozygous and
kept at Unidade de Experimentação Animal (UEA) of the Hospital
de Clínicas de Porto Alegre (HCPA). The animals were maintained
on a 12:12 h light/dark cycle (lights on 0700–1900h) in air condi-
tioned constant temperature (22±1 °C) colony room, with free ac-
cess to water and 20% (w/w) protein commercial chow (NUVILAB)
Porto Alegre, RS, Brazil. Mice genotypes were identiﬁed by speciﬁc
primers using the PCR method. It should be mentioned that previous
studies with the Gcdh−/−mice model used the 129SVJ/C57Bl6 hybrid
model (Koeller et al., 2002; Tretter and Adam-Vizi, 2000; Zinnanti et
al., 2007; Zinnanti et al., 2006). In our experience mice with the
129SvEv background had a higher breeding rate and this was neces-
sary to achieve a signiﬁcant number of age-matched animals.
The animals were allowed to adapt in the room used for behavioral
assessment at least 1 h before the tests. All the taskswere performed be-
tween 1 and 5 p.m. in a sound-attenuated room under low-intensity
light and the genotypes of themice were unknown to the experimenter
during the behavioral and videotape analysis (any-maze software®). All
apparatuses were cleaned with a 10% ethanol solution and then dried
with a paper towel after each trial.
Ethical statement
This study was performed in strict accordance with the EU Directive
2010/63/EU for Animal Experiments and approved by the Ethical Com-
mittee for the Care and Use of Laboratory Animals of HCPA. All efforts
were alsomade to use theminimal number of animals necessary to pro-
duce reliable scientiﬁc data and to minimize the animal discomfort.
Physical and neurological development
Litters were inspected daily between 8 a.m. and 10 a.m. Progress
of physical development was followed throughout the experiment.The date of appearance of coat, eruption of upper incisors, eye open-
ing and weight gain were recorded using previously reported criteria
(da Silva et al., 2004; Mello et al., 1994) described in detail by Smart
and Dobbing (1971). None of the interventions above interfered sig-
niﬁcantly with the adult animals' general normal behavior (e.g. ability
to move, grasp, and climb) and sensory-motor functions.
Rota-rod test
We used 11WT and 10 Gcdh−/−mice in this test. The rota-rod test
was carried out to evaluate balance andmotor coordination (Liu et al.,
2011). Animals were trained for 5 min on rota-rod treadmills at a
rolling speed of 24 rpm. After a 2-min inter-trial interval, the test
was performed. The residence time of the mice on rota-rod treadmills
was recorded for 5 min and an average of the residence time from
three tests (2 min interval each) was used in the calculations.
Climbing cage test
We utilized 11 WT and 10 Gcdh−/− mice in this task. This test was
used to assess motor coordination and central dopaminergic function.
WT and Gcdh−/−mice were placed in the bottom of wire cylinder cages
(30 cm×15 cm×18 cm). The spontaneous activity was videotaped for
10 min and the duration of climbing (all four paws on the wire meson
side of cage) was determined (Hickey et al., 2008).
Grip strength task
We used 11 WT and 11 Gcdh−/− mice in this task. The forelimb
muscle grip strength was determined using a custom-built force
transducer connected to a small support that could be grasped by
the mouse (Fowler et al., 2002). Maximal horizontal and vertical
force was registered during consecutive attempts (three attempts
per mouse by axis) and the result was set as the average of the
three best attempts.
Inhibitory avoidance task
We employed 9 WT and 10 Gcdh−/− mice in this task. The inhibi-
tory avoidance task was assessed in an apparatus consisting of an
acrylic box (22 cm×22 cm×25 cm) whose ﬂoor contained parallel
caliber stainless-steel bars (1 mm diameter) spaced 1 cm apart. A
platform (2 cm×10 cm×10 cm wide) was placed in the center of
the box. In the training session, mice were placed on the platform
and the latency to step-down onto the ﬂoor with the four paws was
measured with an automatic device; mice received three 0.4 mA,
0.7 s each footshock immediately after stepping-down. After they
had received the footshock, they were immediately placed back in
their home cage. The test session was carried out 90 min (to access
short-term memory) and 24 h after training (to access long-term
memory), and step-down latencies (180 s ceiling) were taken as a
measure of memory retention (Rossato et al., 2009).
Footshock-sensitivity test
We utilized 8 WT and 9 Gcdh−/− mice in this test. The animals
were placed into an isolated compartment of a modiﬁed shuttlebox
(22 cm×22 cm×25 cm) and the “up and down” method was
adapted to determine pain thresholds in mice. Mice were allowed
for a 1-min habituation period prior to the start of a series of foot
shocks (1 s) delivered at 10-s intervals. Shock intensities ranged
from 0.1 to 0.9 mA in 0.1 mA increments. Footshock intensities re-
quired to induce “ﬂinch” and “jump” were recorded and these re-
sponses were used as the parameters of pain sensitivity and pain
tolerance, respectively (Botton et al., 2010; Izquierdo et al., 1998a).
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Parametric data were expressed as mean±SEM and analyzed by
the Student t test for unpaired samples and repeated measures
ANOVA using the genotype as the independent variable and sessions
as the repeated measures. Nonparametric data were expressed as me-
dian and interquartile ranges and analyzed using theWilcoxon test to
determinate differences between training and test latencies of the
same group. The Mann–Whitney U test (two-tailed) was used to
compare genotypes. All analyses were performed using the SPSS soft-
ware and GraphPad Prism 4. Differences of Pb0.05 were considered
signiﬁcant.Fig. 2. Assessment of rota-rod as a motor coordination measure in Gcdh−/− and WT
mice. Rota-rod performance testing was performed after 2-min interval of training ses-
sion. Results are presented as mean±SEM of 10–11 animals. No signiﬁcant differences
were observed (Student t test for unpaired samples).Results
Physical and neurodevelopmental studies
We initially observed that body and weight gain of Gcdh−/− mice
was similar to that of WT mice (data not shown). The day of appear-
ance of some physical landmarks and reﬂexes was also evaluated dur-
ing the development. No delay in the day of appearance of coat and
upper incisor eruption was observed in Gcdh−/− mice as compared
to WT mice (results not shown). In contrast, the eye-opening day
was signiﬁcantly delayed in the Gcdh−/− litters since they opened
their eyes at postnatal day 16 while the WT litters opened at postna-
tal day 13 [t (9)=−2.60, Pb0.05].Grip strength task
We also found that Gcdh−/− and WT mice had similar performance
in the grip-strength task, using a vertical wire-grid [t (20)=−0.999;
P>0.05] and a horizontal wire-grid [t (20)=−0.634; P>0.05]
(Fig. 1). The data indicate no loss of strength in the Gcdh−/−mice.Rota-rod test
This test evaluates the animal balance andmotor coordination. Fig. 2
shows the time spent byWT and Gcdh−/−mice on the rota-rod appara-
tus during trial and test sessions. Repeated measures ANOVA analysis
showed no differences between trial×test sessions [F (1,20)=2.96;
P>0.05] and no interaction between genotypes×sessions (trial and
test) [F (1,20)=0.047; P>0.05]. Furthermore, Student t test for unpaired
samples revealed that both groups of animals (WT and Gcdh−/−mice)
spent the same time on the rota-rod apparatus in the trial [t (19)=
0.425; P>0.05] and test [t (19)=0.145; P>0.05] sessions.vertical horizontal
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Fig. 1. Assessment of grip strength task in Gcdh−/− andWTmice. Results are presented
as mean±SEM of 11 animals. No signiﬁcant differences were observed (Student t test
for unpaired samples).Climbing cage test
Next, we observed that the climbing behavior of GCDH deﬁcient
mice was signiﬁcantly higher as compared with that of WT animals
[t (19)=−4.73; Pb0.001] (Fig. 3).
Inhibitory avoidance task
We tested cognitive behavior in GCDH deﬁcient and WT mice by
using the inhibitory avoidance task. It can be observed in Fig. 4 that
Gcdh−/− mice showed a marked reduction of both short- [Z=−2.20;
Pb0.05] and long-term memories [Z=−2.90; Pb0.01] (Fig. 4).
Footshock-sensitivity test
We also submitted GCDH deﬁcient and WT mice to the footshock-
sensitivity test in order to verify whether the decrease of memory re-
tention in the Gcdh−/− mice could be due to an impairment of
footshock sensitivity. It was found that WT and Gcdh−/− mice re-
quired the same footshock intensity for ﬂinch [t (15)=0.950;
P>0.05] and jump [t (15)=0.130; P>0.05] responses, indicating
that both animal groups have similar pain tolerance and sensitivity.
Discussion
The manifestation of motor disability and psychomotor/mental
delay is found in a considerable number of GAI patients with and with-
out preceding crises of encephalopathy (Barić et al., 2003; Blass, 2001;
Kölker et al., 2011; Mushimoto et al., 2011). In this scenario, apart
from the original paper describing the mouse model of GAI (Tretter
and Adam-Vizi, 2000), to the best of our knowledge practically nothing
has been done to investigate physical and neuromotor postnatalWT Gcdh-/-
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Fig. 3. Assessment of climbing behavior in Gcdh−/− and WT mice. Climbing perfor-
mance was analyzed during 10 min. Results are presented as mean±SEM of 10–11 an-
imals. ***Pb0.001, compared to WT mice (Student t test for unpaired samples).
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Fig. 4. Assessment of inhibitory avoidance task in Gcdh−/− and WT mice. Short-term
(STM) and long-term memories (LTM) were assessed 90 min and 24 h after training
session. Results are presented as median and interquartile range of 9–10 mice.
*Pb0.05 and **Pb0.01, compared to WT mice (Mann–Whitney U test).
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fore, in the present work we evaluated physical and neurobehavioral
landmarks during early postnatal development, as well as the perfor-
mance of adult (60-day-old) Gcdh−/− and WT mice in various behav-
ioral tasks aimed to assess motor coordination, climbing behavior,
muscular strength and memory retention.
We ﬁrst observed that Gcdh−/−mice had the same physical devel-
opment as that of WT mice, implying that they did not have loss of
appetite or malnutrition. This observation is important since mal-
nourished animals may behave differently in neurobehavioral tests
(Davis and Squire, 1984; Smart and Dobbing, 1971). Furthermore,
muscular strength did not differ between Gcdh−/− and WT mice, in-
dicating that GCDH deﬁciency does not lead to muscle and bone
mass loss (Windahl et al., 2011).
The date of appearance of coat or upper incisor eruption was also
the same for Gcdh−/−mice and controls. However, Gcdh−/−mice had
a signiﬁcant delayed eye opening, implying a mild impairment of
neurodevelopment in these animals. Considering that changes in
the visual cortex may reﬂect a delay in eye opening (Koehler et al.,
2011), neuronal activity in the visual cortex may be compromised
in Gcdh−/− mice.
We also veriﬁed that there was no difference in the performance
of 60-day-old Gcdh−/− mice in the rota-rod test, as compared to
age-matched WT mice. Since this task is used as a reliable index of
motor coordination, it is concluded that motor coordination is not
mainly altered in Gcdh−/−mice. Our ﬁndings are similar to those pre-
viously observed in 60-day-old Gcdh−/− mice using the accelerating
rota-rod apparatus (Tretter and Adam-Vizi, 2000). However, these in-
vestigators found a mild but signiﬁcant impairment of motor coordi-
nation in younger (20-day-old) GCDH deﬁcient animals, which
probably recovered during development. These slight differences
may be possibly due to the distinct methods and/or genetic back-
ground of the mice used by these investigators.
We also observed in our study that climbing behavior was signiﬁ-
cantly higher in Gcdh−/− mice. Since this behavior has been attributed
to the stimulation of D1 and D2 receptors (Fetsko et al., 2003; Moore
and Axton, 1988; Protais et al., 1976), it is suggested that activated dopa-
minergic receptors,which are involved in the corticostriatal circuits (Kim
et al., 1996), may underlie the increased climbing behavior of Gcdh−/−
mice. This is strengthened by the observations that dopamine-induced
climbing can be blocked by dopamine D1 and/or D2 receptor antagonists
(Ferrari and Giuliani, 1995; Moore and Axton, 1988).
The most interesting ﬁnding of the present work was the observa-
tion that Gcdh−/− mice presented a signiﬁcant deﬁcit of both short-
and long-termmemories in the inhibitory avoidance task. In this con-
text, since performance of animals on the inhibitory avoidance task
depends on several sensory stimuli including spatial and visual per-
ception, sensitivity to pain, and emotional fear-driven components
(Cammarota et al., 2007), we also evaluated the performance of theanimals in the footshock-sensitivity test in order to verify if the deﬁ-
cient inhibitory avoidance presented by GCDH deﬁcient mice could be
attributed to an altered footshock tolerance. That was not the case,
reinforcing the presumption that the Gcdh−/− mice had cognition
deﬁcit in the inhibitory avoidance task.
Otherwise, it is stressed that cognition depends on integrated
brain neuromodulatory systems and that the dopaminergic pathway
is important for developmental plasticity, functional plasticity and
memory formation (Izquierdo and McGaugh, 2000; Izquierdo and
Medina, 1997). Furthermore, increased dopamine extracellular levels
are related with cognitive deﬁcits (Nieoullon, 2002). Therefore, al-
though we cannot at the present establish the exact underlying
mechanisms involved in the increased climbing and deﬁcit of short-
and long term memories of Gcdh−/− mice, it is possible that an acti-
vated dopaminergic system may explain these behavioral alterations
(Rossato et al., 2009; Vianna et al., 2004). Taken together, it seems
justiﬁed to investigate in further studies the role of the dopaminergic
activity on the behavioral alterations observed in the Gcdh−/−mice in
the present work in order to establish the relevance of this neuro-
transmission system in GAI.
The present results, allied to previous ﬁndings showing mild learn-
ing defects observed in the habituation to repeated startle stimuli in
the Gcdh−/−mice (Tretter and Adam-Vizi, 2000), indicate that this an-
imal model presents some degree of cognitive dysfunction. Thus, these
data derived from Gcdh−/− mice indicate that the psychomotor and
mental development should be studied in much more detail in GAI pa-
tients. Furthermore, since neurotoxic effects of GA and 3OHGA have
been extensively demonstrated (Dalcin et al., 2007; Ferreira et al.,
2005; Latini et al., 2007; Olivera et al., 2008; Porciúncula et al., 2000;
Rosa et al., 2004), it is conceivable that persistent brain accumulation
of these organic acids may disrupt essential pathways in the CNS neces-
sary for learning/memory. Interestingly, a recent report revealed that
GA chronic administration to rats during early development provokes
long-term spatial cognitive deﬁcits that could not be attributed to al-
tered motor activity or anxiety (Ferreira et al., 2007). The authors sug-
gest that this deﬁcient cognitive behavior could have been possibly
caused by high-sustained brain concentrations of GA compromising
learning/memory processes.
Although we did not perform histopathological studies, we pre-
sume that acute and severe striatal degeneration did not occur in
our group of Gcdh−/− mice since the animals did not suffer encepha-
lopathic crises or presented dystonia/dyskinesia. Therefore, it seems
reasonable to assume that chronic alterations of critical cerebral
structures involved in learning/memory and climbing were probably
associated with the behavioral alterations identiﬁed in the GCDH de-
ﬁcient mice. In this scenario, the striatum might be somehow in-
volved in these behavioral disturbances especially the increased
climbing behavior because of the high activity of the dopaminergic
system in this structure (Arias-Carrión et al., 2010; Bueno-Nava et
al., 2012; Gerfen et al., 1990; Surmeier et al., 2011; Tsai et al., 2012).
We cannot also exclude the possibility that abnormalities of the cere-
bral cortex, hippocampus and amygdala participated in the cognitive
deﬁcit veriﬁed in the Gcdh−/− animals, since these structures are es-
sential for short- and long-termmemories in the inhibitory avoidance
task (Izquierdo et al., 1998a,b; Rossato et al., 2009; Vianna et al.,
2004) and were previously shown to be damaged in Gcdh−/− mice
(Zinnanti et al., 2007; Zinnanti et al., 2006).
Now, in what regards to the affected GAI patients, it appears that the
variable degree of psychological/intellectual delay observed in recent
studies does not depend on the genotype but rather on the time of the
diagnosis and the establishment of appropriate treatment, the more se-
vere phenotypes occurring in patients detected at older ages and the bet-
ter outcome observed in patients with early detection (Barić et al., 2003;
Haworth et al., 1991; Kölker et al., 2011; Mushimoto et al., 2011). Fur-
thermore, it has not beenwell established yetwhether the cognitive def-
icit presented by these patients is secondary to encephalopathic crises
141E.N.B. Busanello et al. / Life Sciences 92 (2013) 137–142with striatum damage or a consequence of progressive damage of cere-
bral structures causing neurobehavioral deﬁcits. Considering our present
data in Gcdh−/−mice showing cognitive deﬁcit with no acute encepha-
lopathy and the observations that over 20% of GAI patients presents neu-
rological symptomatology in the absence of encephalopathic crises,
being categorized as insidious-onset (Busquets et al., 2000) and late-
onset patients (Kölker et al., 2011; Külkens et al., 2005; Mushimoto et
al., 2011), it is presumed that chronic damage to the brain rather than
acute striatum degeneration is more frequently correlated with the var-
iable mental development delay accompanying the neurological dys-
function in GAI.
Conclusions
In conclusion, we show for the ﬁrst time a deﬁcit of the short-term
and long-termmemories and induction of climbing behavior in young
adult Gcdh−/− mice. Our present data are particularly interesting in
view of the psychomotor/mental delay that occurs in a signiﬁcant
number of adult GAI patients (Barić et al., 2003; Kölker et al., 2011;
Mushimoto et al., 2011).
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